iBio hires Molly Carr as Chief Medical Officer
iBio, Inc. has entered into an Employment Agreement with Molly Carr, who will serve as Chief Medical Officer and report to the CEO. The effective date is July 31, 2026.
View filing at SEC.gov →2 most recent filings and news items mentioning IBIO. Updated every 60 seconds.
curl "https://api.brieftape.com/v1/tickers/IBIO/news?limit=20"
Pull IBIO filings straight into your trading bot, model, or app.
Get an API key — free tier: 10,000 calls/dayiBio, Inc. has entered into an Employment Agreement with Molly Carr, who will serve as Chief Medical Officer and report to the CEO. The effective date is July 31, 2026.
View filing at SEC.gov →iBio reported that a single dose of IBIO-610 achieved near-complete suppression of active Activin E levels in obese NHPs for eight weeks. This data supports a potential long-acting antibody therapy approach for obesity and enhances the outlook for combination treatments with sema
View filing at SEC.gov →